Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An update from Paragon Care Limited ( (AU:PGC) ) is now available.
Paragon Care Limited has released its FY26 half-year report, highlighting its evolution into a leading diversified healthcare provider across the Asia-Pacific region. The company underscores its strategic transformation following the 2024 merger with Clifford Hallam and reiterates its role in making healthcare simpler, smarter and more accessible throughout its markets.
The most recent analyst rating on (AU:PGC) stock is a Hold with a A$0.19 price target. To see the full list of analyst forecasts on Paragon Care Limited stock, see the AU:PGC Stock Forecast page.
More about Paragon Care Limited
Paragon Care Limited is an ASX-listed diversified healthcare distributor and manufacturer operating across the Asia-Pacific region. The company supplies pharmaceuticals, capital equipment, diagnostics, medical consumables, devices and complementary medicines, building on a century-long presence that began in Australia in 1918 and was reshaped by its 2024 merger with Clifford Hallam.
Average Trading Volume: 1,116,734
Technical Sentiment Signal: Sell
Current Market Cap: A$339.3M
For detailed information about PGC stock, go to TipRanks’ Stock Analysis page.